Stephen Pollitt
Angel investor in Mountain View
Mountain View, California
Stephen Pollitt, Angel investor in Mountain View is an active investor based in Mountain View, California. This profile covers what Stephen Pollitt backs, at which stage, and how founders can reach out in 2026.
Dr. Stephen Pollitt is an Angel Investor. Dr. Pollitt served as Board Member at Sand Hill Angels. He has over 19 years experience in the biotechnology and pharmaceutical industries. His career began with Scios (later acquired by Johnson & Johnson) where he was in charge of host cell development for biologics heading into clinical testing. One of these products, Natrecor, received FDA approval in 2001 as a treatment for acute congestive heart failure. He served as Project Leader on several early phase drug discovery and development projects, most recently as Compound Development Team Lead for VEGF-121. He also served on the target selection committee which evaluated targets for the company's small molecule development platform. Steve is currently an independent consultant working with drug development teams at start-ups and virtual companies where he assists with management of the drug development process and molecular biology of protein expression. Steve holds a Ph.D. in Molecular Biology from Purdue University, West Lafayette, IN and a B.S. in Chemistry with honors from the University of Georgia. He was a postdoctoral fellow at SUNY, Stony Brook and a Research Assistant Professor at the University of Medicine and Dentistry of NJ in Piscataway.
- Investor type
- Angel
- Stages
- Early Stage Venture
- Invests in
- Biotech & PharmaHardware & Deep Tech
- Location
- Mountain View, California
- Typical check
- $500K
- Past investments
- 4
Notable investments
Sand Hill AngelsMojo MobilityScios/Johnson & JohnsonSciosHow to reach Stephen Pollitt
Angels and operators like Stephen Pollitt reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Stephen Pollitt." Round Funded investor database, updated September 9, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/stephen-pollitt
Frequently Asked Questions
What does Stephen Pollitt invest in?
Stephen Pollitt invests in Biotech & Pharma and Hardware & Deep Tech, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Stephen Pollitt invest at?
Stephen Pollitt typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Stephen Pollitt's typical check size?
Stephen Pollitt typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.